PR inside: October 5, 2026 Deadline Approaching: Join Class Action Against ARS ...
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / October 4, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) securities.
If you suffered a loss on your ARS Pharmaceuticals investment and would like to explore a potential recovery under the federal securities laws, Learn about ARS Pharmaceuticals Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates.
THE LAWSUIT: A class action securities lawsuit was filed against ARS Pharmaceuticals, ..
https://reports.pr-inside.com/october-5 ... 230162.htm
Copyright PR-Inside.com 2026
